MODULATING SYNGAP

Disclosed are methods and compositions for treating a neurodevelopmental disorder in a subject in need thereof. In some aspects, the method includes administering an effective amount of an agent, wherein administering the agent modulates expression of one or more isoforms of synaptic GTPase-activati...

Full description

Saved in:
Bibliographic Details
Main Authors Huganir, Richard, Hong, Ingie, Araki, Yoichi
Format Patent
LanguageEnglish
Published 23.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are methods and compositions for treating a neurodevelopmental disorder in a subject in need thereof. In some aspects, the method includes administering an effective amount of an agent, wherein administering the agent modulates expression of one or more isoforms of synaptic GTPase-activating protein (SynGAP).
Bibliography:Application Number: US202318185743